Key takeaway: In atrial fibrillation, a brief “run” of wide-ish beats after a long–short sequence is often Ashman phenomenon—benign aberrancy that should not be treated as VT or pre-excitation.
A 68-year-old man complains that his chronic, irregular heartbeat has been more bothersome in the last 24 hours. He states that he is compliant with taking his digoxin. Initial findings on electrocardiography (ECG) shows atrial fibrillation (AF) with a ventricular rate of 89 beats/minute (see Figure). During the patient's workup, a nurse alerts you to a sudden run of fast beats on the patient's monitor.
What is the most prudent reaction to the rhythm shown in this image?
Answer Options:
The monitor strip is most consistent with AF with Ashman phenomenon—intermittent aberrant conduction (often RBBB-shaped) that occurs when a long RR interval is followed by a short RR interval. The long cycle prolongs bundle-branch refractoriness; the subsequent early beat arrives while one bundle (classically the right bundle) is still refractory, producing a wide QRS that can look like PVCs or nonsustained VT.
This is a classic boards trap: the wide beats look scary, but the patient’s baseline rhythm is AF at a controlled ventricular rate and the “run” is explained by rate-related aberrancy, not a malignant ventricular rhythm. Per AHA ACLS tachycardia principles (2020), management hinges on stability and correct rhythm identification; benign aberrancy does not warrant empiric amiodarone/lidocaine. The prudent step is no change—continue the AF evaluation/management (rate control strategy, anticoagulation assessment, evaluate triggers), rather than treating the aberrant beats.
Why This Family Medicine Question Is Frequently Missed
| Option | What It Tests / Implies | Why It’s Wrong Here |
|---|---|---|
| Avoid atrioventricular-nodal blockers in this patient. | Concern for pre-excitation (e.g., WPW) where AV-nodal blockers can be dangerous | Ashman is not pre-excitation; the wide QRS is aberrancy after long–short cycling, not delta waves/rapid pre-excited AF. |
| Check a digoxin level. | Digoxin toxicity evaluation | Digoxin toxicity can cause many dysrhythmias, but this pattern is classic Ashman; no toxicity features are provided (e.g., GI/visual symptoms, bradyarrhythmias, bidirectional VT). |
| Give amiodarone if the run of fast beats becomes sustained. | Treat presumed VT with amiodarone if sustained | Misidentifies aberrantly conducted AF beats as VT; ACLS antiarrhythmics are not indicated for benign aberrancy. |
| Start an intravenous lidocaine drip if the patient has > 6 consecutive beats of the same fast rhythm. | Treat presumed ventricular ectopy with lidocaine | Lidocaine is not a “PVC count” therapy; also this isn’t established VT/PVC-driven instability—pattern fits Ashman. |
| No change in the patient's workup. | Recognize benign aberrancy; avoid overtreatment | Correct: Ashman phenomenon itself requires no specific treatment beyond routine AF care. |
In atrial fibrillation, a wide QRS beat/run after a long–short RR sequence is Ashman phenomenon (aberrancy), not VT—don’t treat it with antiarrhythmics if the patient is stable.
The item exploits “wide-complex panic”: a brief run of wide beats on telemetry tempts you to escalate to amiodarone/lidocaine or to avoid AV-nodal blockers (as in WPW). Boards reward recognizing that not all wide QRS complexes are ventricular—in AF, aberrancy from physiologic refractoriness (Ashman) is common and benign.
A patient with AF has an irregularly irregular rhythm with occasional wide QRS complexes. The wide complexes occur immediately after a long RR interval followed by a short RR interval and look like RBBB. He is asymptomatic and normotensive. Next step?
A patient in AF develops a sudden regular wide-complex tachycardia at 180/min with hypotension and chest pain. Best next step?
Irregular wide-complex tachycardia in a young patient shows varying QRS morphologies and very rapid ventricular rates >200 with intermittent slurring upstroke. Best medication to avoid?
Which rhythm is most classically associated with digoxin toxicity (in the right clinical setting)?
Which feature most supports Ashman phenomenon rather than PVCs in AF?
How would your management differ between (1) AF with intermittent Ashman aberrancy in a stable patient, (2) pre-excited AF (WPW) with irregular wide complexes, and (3) unstable regular wide-complex tachycardia?
Q1: What single ECG clue most strongly suggests Ashman phenomenon?
A: The long–short RR sequence preceding a wide QRS in AF; ABIM-style questions often hinge on this pattern recognition.
Q2: Do Ashman beats require antiarrhythmic therapy?
A: No—Ashman reflects aberrant conduction, not a ventricular tachyarrhythmia; exams expect “recognize and don’t overtreat.”
Q3: When should you treat wide-complex tachycardia aggressively?
A: If the patient is unstable or the rhythm is sustained/regular and concerning for VT—per AHA ACLS Adult Tachycardia (2020), unstable tachycardia → synchronized cardioversion.
Q4: Why does the right bundle branch pattern show up so often with Ashman?
A: The right bundle often has a longer refractory period and is more likely to be refractory after cycle-length changes, producing an RBBB morphology.
Find this and other Family Medicine exam prep questions in Med-Challenger Family Medicine Review with CME
Try for free and save. Ace your exams and meet your CME/MOC requirements for just $35 a month!
No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.
For personal medical education that includes board's prep, MOC, and CME requirements, Med-Challenger has you covered in Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, OBGYN, Physician Assistants, and Nurse Practitioners.